Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 8, 2012 - Issue 5
Submit an article Journal homepage
29
Views
3
CrossRef citations to date
0
Altmetric
Editorial

CD4+ T cells suppress immune response to cancer: novel targets for antitumor efforts

Allison Nelson Department of Internal Medicine, Division of Translational Medicine, Nanomedicine Research Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA
,
Sajitha Nair Department of Internal Medicine, Division of Translational Medicine, Nanomedicine Research Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA
&
Srinivas Nagaraj Department of Internal Medicine, Division of Translational Medicine, Nanomedicine Research Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. [email protected]
Pages 401-403 | Published online: 10 Jan 2014

References

  • Dolcetti L Peranzoni E Ugel S et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40(1), 22–35 (2010).
  • Nagaraj S Youn JI Weber H et al. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin. Cancer Res. 16(6), 1812–1823 (2010).
  • Nagaraj S Schrum AG Cho HI Celis E Gabrilovich DI. Mechanism of T-cell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 184(6), 3106–3116 (2010).
  • Nagaraj S Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer J. 16(4), 348–353 (2010).
  • Herber DL Cao W Nefedova Y et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16(8), 880–886 (2010).
  • Ostrand-Rosenberg S. Myeloid-derived suppressor cells: more mechanisms for inhibiting anti-tumor immunity. Cancer Immunol. Immunother. 59(10), 1593–1600 (2010).
  • Nagaraj S Gupta K Pisarev V et al. Altered recognition of antigen is a mechanism of CD8+ T-cell tolerance in cancer. Nat. Med. 13(7), 828–835 (2007).
  • Almand B Clark JI Nikitina E et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166(1), 678–689 (2001).
  • Gabrilovich DI Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9(3), 162–174 (2009).
  • Kodumudi KN Woan K Gilvary DL Sahakian E Wei S Djeu JY. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin. Cancer Res. 16(18), 4583–4594 (2010).
  • Solito S Bronte V Mandruzzato S. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J. Leukoc. Biol. 90(1), 31–36 (2011).
  • Chalmin F Ladoire S Mignot G et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 120(2), 457–471 (2010).
  • Kodumudi KN Woan K Gilvary DL Sahakian E Wei S Djeu JY. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin. Cancer Res. 16(18), 4583–4594 (2010).
  • Sinha P Clements VK Ostrand-Rosenberg S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174(2), 636–645 (2005).
  • Kusmartsev S Nefedova Y Yoder D Gabrilovich DI. Antigen-specific inhibition of CD8+ T-cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172(2), 989–999 (2004).
  • Kusmartsev S Nagaraj S Gabrilovich DI. Tumor-associated CD8+ T-cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175(7), 4583–4592 (2005).
  • Serafini P Mgebroff S Noonan K Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68(13), 5439–5449 (2008).
  • Nagaraj S Nelson A Youn J Cheng P Quiceno D Gabrilovich D. Antigen-specific CD4+ T-cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 72(4), 928–938 (2012).
  • Kortylewski M Kujawski M Wang T et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent anti-tumor immunity. Nat. Med. 11(12), 1314–1321 (2005).
  • Ko JS Zea AH Rini BI et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15(6), 2148–2157 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.